CUE - Cue Biopharma, Inc. - SEC Form 4 Insider Trading Screener
4 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-08-29 | CUE | Millar Kerri-Ann | VP-Finance | P - Purchase | $8.48 | +1,000 | 1,000 | New | +$8,480 | ||||||
2018-08-16 | CUE | Passeri Daniel R | CEO, Pres | P - Purchase | $8.09 | +6,000 | 47,600 | +14% | +$48,510 | ||||||
2018-06-29 | CUE | Passeri Daniel R | CEO, Pres | P - Purchase | $11.97 | +1,600 | 41,600 | +4% | +$19,152 | ||||||
2017-12-27 | CUE | Pienta Kenneth | Chief Medical Officer | P - Purchase | $7.50 | +2,000 | 2,000 | New | +$15,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |